Bioneex Interviews

We actively promote our platform Member companies. Would you like to be interviewed?

Contact us
Bionex
AllGene TherapyClinical StageOncologyInfectious DiseasesPreclinical StageCNSImmuno-OncologyNeurologyNephrologyCardiovascular TherapiesCancer TherapiesCell TherapiesImmunotherapies
interview

Interview with Founder & Chief Scientific Officer of OX2 Therapeutics, Dr. Michael Olin

Fri Jun 18 2021 15:25:19 GMT+0000 (Coordinated Universal Time)

Contact us
Schedule a call or send us a message
Schedule Call
Contact us